ghk cu peptide oral or topical GHK-Cu Copper 0.5% (topical foam) ENHANCED EXTENDS PEPTIDE PLATFORM WITH

REV.06.25

Incretins: pathophysiological and therapeutic implications of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1

It does not affect the nervous system in ways that produce anxiety or sleep problems

While GLP-1 agonists may produce greater total weight loss, AOD-9604 more selectively targets fat tissue while preserving muscle mass

GHK-Cu is a complex of copper and glycyl-l-histidyl-l-lysine (GHK), a peptide present in human plasma, saliva, and urine that decreases in concentration as we age

Senolytic peptide FOXO4-dri selectively removes senescent cells from in vitro expanded human chondrocytes